Trial Profile

Phase I trial evaluating the immunogenicity of H4IC in patients with latent tuberculosis who have received the BCG vaccine

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 17 Jan 2012

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs H4IC (Primary)
Indications Tuberculosis
Focus Pharmacodynamics

Most Recent Events

17 Jan 2012 Enrolment was completed in 2008, and analysis of the clinical samples is ongoing, according to sanofi pasteur.
04 Dec 2007 Status change from planning to recruiting.
26 Mar 2007 New trial record.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com